BARCLAYS PLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 150 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2014. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$0
-100.0%
78
-98.9%
0.00%
Q3 2018$3,000
-96.6%
7,016
-96.0%
0.00%
Q2 2018$89,000
-70.5%
176,755
+36.1%
0.00%
Q1 2018$302,000
+411.9%
129,854
+522.4%
0.00%
Q4 2017$59,000
+353.8%
20,865
+350.1%
0.00%
Q3 2017$13,000
+550.0%
4,636
+337.8%
0.00%
Q2 2017$2,000
-97.1%
1,059
-94.3%
0.00%
Q1 2017$68,000
+112.5%
18,641
+103.3%
0.00%
Q4 2016$32,000
-3.0%
9,170
+9.4%
0.00%
Q3 2016$33,000
-66.7%
8,384
-74.6%
0.00%
Q1 2016$99,000
-96.7%
33,050
-83.6%
0.00%
-100.0%
Q4 2015$3,026,000
+984.6%
201,714
+624.7%
0.00%
Q3 2015$279,000
+125.0%
27,835
+461.9%
0.00%
Q2 2015$124,000
-83.9%
4,954
-82.6%
0.00%
-100.0%
Q1 2015$769,000
-78.7%
28,493
-85.8%
0.00%
-66.7%
Q4 2014$3,613,000
+125.5%
200,688
+50.3%
0.00%
+50.0%
Q3 2014$1,602,000
-21.8%
133,486
+4.2%
0.00%0.0%
Q2 2014$2,049,000
-17.2%
128,078
-12.1%
0.00%
-33.3%
Q1 2014$2,476,000
-59.9%
145,641
-43.4%
0.00%
-50.0%
Q4 2013$6,174,000
+24.9%
257,187
+82.1%
0.01%0.0%
Q3 2013$4,944,000
+2587.0%
141,263
+1095.8%
0.01%
Q2 2013$184,00011,8130.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2014
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders